List View Detail View 351-375 of 820 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 14 15 16 ... 33 Next Product Clone Appl. Reg Cat# Size Price Quantity Spark PLUS V475™ anti-human CD45 Antibody HI30 FC RUO 390505 25 tests 165 CHF Spark PLUS UV395™ anti-mouse CD45 Antibody 30-F11 FC RUO 103191 25 µg 160 CHF 103192 100 µg 320 CHF Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC RUO 103197 25 µg 132 CHF 103198 100 µg 311 CHF Cell-Vive™ GMP Ultra-LEAF™ Purified anti-HU CD45 RecAb SF HI30.Rec FC GMP-RUO 390603 100 µg 328 CHF 390604 1 mg 1683 CHF Cell-Vive™ GMP Ultra-LEAF™ Biotin anti-HU CD45 RecAb SF HI30.Rec FC GMP-RUO 390605 100 µg 492 CHF 390606 1 mg 2525 CHF Spark Red™ 718 anti-human CD45 Recombinant (Flexi-Fluor™) Antibody QA17A19 FC RUO 285356 50 µg 375 CHF Spark Blue™ 574 anti-human CD45 Recombinant (Flexi-Fluor™) Antibody QA17A19 FC RUO 285328 50 µg 394 CHF Spark Red™ 718 anti-rat CD45 (Flexi-Fluor™) Antibody OX-1 FC RUO 285344 50 µg 288 CHF Spark Blue™ 574 anti-rat CD45 (Flexi-Fluor™) Antibody OX-1 FC RUO 285312 50 µg 336 CHF Spark Blue™ 550 anti-human CD45 Recombinant (Flexi-Fluor™) Antibody QA17A19 FC RUO 285293 50 µg 394 CHF Spark Blue™ 550 anti-rat CD45 (Flexi-Fluor™) Antibody OX-1 FC RUO 285278 50 µg 336 CHF Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) Antibody S18009F FC RUO 285549 50 µg 336 CHF Spark YG™ 581 anti-human CD45 (Flexi-Fluor™) Antibody 2D1 FC RUO 285376 50 µg 394 CHF Spark YG™ 581 anti-human CD45 (Flexi-Fluor™) Antibody HI30 FC RUO 285397 50 µg 394 CHF Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) Antibody 30-F11 FC RUO 285378 50 µg 336 CHF PE/Dazzle™ 594 anti-human CD45 Antibody 2D1 FC RUO 368529 25 tests 141 CHF 368530 100 tests 347 CHF PE/Dazzle™ 594 anti-human CD45 Antibody HI30 FC RUO 304051 25 tests 143 CHF 304052 100 tests 351 CHF GMP PE/Dazzle™ 594 anti-human CD45 Antibody HI30 FC GMP-RUO 260178 100 tests 452 CHF PE/Dazzle™ 594 anti-human CD45 HI30 FC ASR 982308 500 µL 467 CHF Results Per Page: 25 50 100 200 Previous 1 ... 14 15 16 ... 33 Next
Follow Us